Key result
Pathogenic DCM and ACM variants reveal distinct right and left ventricular responses and genotype-specific pathways.
Why the study?
Pathogenic variants causing dilated and arrhythmogenic cardiomyopathies convey high risks for heart failure through unknown mechanisms.
Observational (n=79)
Single nucleus RNA sequencing of human hearts with DCM and ACM reveals distinct right and left ventricular responses and genotype-associated pathways, suggesting novel therapeutic targets.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Only this level of resolution allows us to see that cardiomyopathies do not uniformly trigger the same pathological pathways. Rather, different mutations evoked specific and some shared responses that lead to heart failure. These genotype-specific responses point to the importance of genotyping.”
“Our findings hold enormous potential for rethinking how we treat heart failure and point to the importance of understanding its root causes and the mutations that lead to changes that may alter how the heart functions. This is fundamental research, but it identifies targets that can be experimentally pursued to propel future therapeutics. Our findings also point to the importance of genotyping — not only does genotyping empower research but it can also lead to better, personalized treatment for patients.”
“Our study provides a paradigm shift demonstrating that not all heart failure is the same, suggesting patients might benefit from specific treatments. To move towards precision and interceptive medicine we now need to see what changes we discover in earlier stages of the disease.”
Highlights chamber-specific transcriptional responses in genetic cardiomyopathies; hypothesis-generating for targeted therapies, requiring prospective validation before clinical translation.
Pathogenic variants in genes that cause dilated (DCM) and arrhythmogenic cardiomyopathies (ACM) convey high risks for the development of heart failure (HF) through unknown mechanisms. Using single nucleus RNA sequencing (snRNAseq), we characterized the transcriptome of 880,000 nuclei from 18 control and 61 failing, non-ischemic human hearts with pathogenic variants in DCM and ACM genes or idiopathic disease. We performed genotype-stratified analyses of the ventricular cell lineages and transcriptional states. The resultant DCM and ACM ventricular cell atlas demonstrated distinct right and left ventricular responses, highlighting genotype-associated pathways, intercellular interactions, and differential gene expression at single cell resolution. Together these data illuminate both shared and distinct cellular and molecular architectures of human HF and suggest novel candidate therapeutic targets. Funding Acknowledgement Type of funding sources: Other. Main funding source(s): Chan Zuckerberg FoundationLeducq Foundation
No takes yet. Share an insight, caveat, or question.
Reichart et al. (2022) conducted an observational in Dilated and arrhythmogenic cardiomyopathies (n=79). Pathogenic variants in DCM and ACM genes vs. Control hearts was evaluated on Transcriptome characterization of ventricular cell lineages and transcriptional states. Pathogenic variants in DCM and ACM genes demonstrated distinct right and left ventricular responses, highlighting genotype-associated pathways and differential gene expression at single cell resolution.
Synapse has enriched 10 related papers. Consider them for comparative context: